Kenneth Gardner-Smith - 05 Oct 2026 Form 4 Insider Report for ACCENDRA HEALTH INC/VA/ (ACH)

Reporting relationship: President & CEO, Director
Issuer ticker: ACH
Reported as of: 05 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Oct 2026, 20:15:32 UTC
Prior SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: Kenneth Gardner-Smith by Rosemarie France, POA

Filing notes and source

Key filing fact

Kenneth Gardner-Smith filed Form 4 for ACCENDRA HEALTH INC/VA/ (ACH) on 06 Oct 2026.

Key facts

This page summarizes Kenneth Gardner-Smith's Form 4 filing for ACCENDRA HEALTH INC/VA/ (ACH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Oct 2026, 20:15.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001914198 Primary reporting owner

Gardner-Smith Kenneth

Relationship: President & CEO, Director
Address: ACCENDRA HEALTH, INC., 4435 WATERFRONT DRIVE, GLEN ALLEN
Signature: Kenneth Gardner-Smith by Rosemarie France, POA
Signature date: 06 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACH transaction

Common Stock

Award

Transaction value
Shares: +283,554
Change %: +329%
Price: $0.000000^*
Shares after: 369,667
Date: 05 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Restricted stock grant which vests one-third per year over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .